Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis

被引:60
|
作者
Pearce, Fiona A. [1 ,2 ]
Craven, Anthea [3 ]
Merkel, Peter A. [4 ,5 ]
Luqmani, Raashid A. [3 ]
Watts, Richard A. [6 ,7 ]
机构
[1] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham, England
[2] Nottingham Univ Hosp NHS Trust, Dept Rheumatol, Nottingham, England
[3] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England
[4] Univ Penn, Div Rheumatol, Philadelphia, PA 19104 USA
[5] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
[6] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England
[7] Ipswich Hosp NHS Trust, Dept Rheumatol, Ipswich, Suffolk, England
关键词
ANCA-vasculitis; epidemiology; PR3-ANCA; MPO-ANCA; ANCA-ASSOCIATED VASCULITIS; SYSTEMIC VASCULITIS; CLASSIFICATION; GRANULOMATOSIS; EPIDEMIOLOGY; POLYANGIITIS; ALLELES;
D O I
10.1093/rheumatology/kex293
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. There are few data on clinical profiles of ANCA-associated vasculitis (AAV) in different ethnic populations. The aim of this study was to examine the differences in the ANCA type and clinical features of AAV between populations using the Diagnostic and Classification Criteria in Vasculitis Study (DCVAS) dataset. Methods. The DCVAS is an international, multicentre, observational study recruiting in 133 sites. Eight ethnic categories were analysed: Northern European, Caucasian American, Southern European, Middle Eastern/Turkish, Chinese, Japanese, Indian subcontinent and other. ANCA type was categorized as myeloperoxidase (MPO), PR3 and ANCA negative. Organ system involvement was recorded using a standard dataset. Differences were analysed by chi-squared tests using a Bonferroni correction and logistic regression (adjusting for age and sex). Northern European was the reference population. Results. Data from 1217 patients with AAV were available and the 967 (79.5%) patients recruited by rheumatology departments were analysed to reduce confounding by recruitment specialty. There were differences in ANCA type between ethnic categories (P < 0.001): MPO-ANCA was more common than PR3-ANCA in Japanese, Chinese and Southern Europeans; PR3-ANCA was more common in the other groups. Compared with Northern Europeans, Japanese had a nearly 60-fold increased chance of having MPO-ANCA (vs PR3-ANCA) [odds ratio (OR) 59.2 (95% CI 8.0, 440.7), P < 0.001] and Chinese had a nearly 7-times increased chance [OR 6.8 (95% CI 2.6, 17.8), P < 0.001]. Ophthalmologic and otorhinolaryngologic involvement were less common in Japanese and Chinese populations than Northern Europeans; otherwise, there were few differences in organ involvement between ethnic groups. Conclusion. This study confirms the previously observed differential occurrence of MPO-AAV and PR3-AAV between different ethnic groups.
引用
收藏
页码:1962 / 1969
页数:8
相关论文
共 50 条
  • [21] Renal transplantation in anti-neutrophil cytoplasmic antibody-associated vasculitis
    Hruskova, Zdenka
    Geetha, Duvuru
    Tesar, Vladimir
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 : i159 - i163
  • [22] Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis
    Tervaert, JWC
    Stegeman, CA
    Kallenberg, CGM
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2001, 10 (02): : 211 - 217
  • [23] Influenza vaccination and anti-neutrophil cytoplasmic antibody-associated vasculitis
    Wiwanitkit, Viroj
    NEPHROLOGY, 2015, 20 (07) : 511 - 512
  • [24] Tongue necrosis in anti-neutrophil myeloperoxidase antibody-associated vasculitis
    Korsten, Peter
    Hakroush, Samy
    Roedel, Ralph
    Tampe, Bjoern
    RHEUMATOLOGY, 2024, 63 (02) : E61 - E62
  • [25] AN OVERVIEW OF PHARMACOTHERAPY FOR ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS
    Stasi, R.
    DRUGS OF TODAY, 2010, 46 (12) : 919 - 928
  • [26] Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Kidney Transplantation
    Binda, Valentina
    Favi, Evaldo
    Calatroni, Marta
    Moroni, Gabriella
    MEDICINA-LITHUANIA, 2021, 57 (12):
  • [27] Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis
    Lee, Richard W.
    D'Cruz, David P.
    DRUGS, 2008, 68 (06) : 747 - 770
  • [28] Genetic aspects of anti-neutrophil cytoplasmic antibody-associated vasculitis
    Alberici, Federico
    Martorana, Davide
    Vaglio, Augusto
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 : i37 - i45
  • [29] Animal models of anti-neutrophil cytoplasmic antibody-associated vasculitis
    Coughlan, A. M.
    Freeley, S. J.
    Robson, M. G.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2012, 169 (03): : 229 - 237
  • [30] Mouse Models of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
    Gan, Poh-Yi
    Ooi, Joshua D.
    Kitching, A. Richard
    Holdsworth, Stephen R.
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (18) : 2380 - 2390